LGALS3 and cancer: The studies show that cancer-associated MUC1 mucin is one of the most desirable, natural ligands for galectin-3, and that such interactions are mediated mostly via the binding of Gal-3 to the T carbohydrate (Figure 3), a prominent tumor-associated antigen on MUC1 mucin.